The U.S. Food and Drug Administration (FDA) now requires TV and radio drug ads to be clearer and more direct. The new ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

While many companies focus on enhancing existing drug development workflows ... generation projects for international clients ...

The clinical-stage biopharmaceutical company said it has enough cash to reach the milestones it laid out for 2025.

Researchers are testing a product commonly used to treat ticks and fleas on pets to target fly and mosquito larvae with the goal of helping reduce the spread of diseases carried by these insects.

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...

Syndax Pharmaceuticals advances Revumenib for relapsed AML with FDA decision pending. See why SNDX stock is a key player in ...

Arkansas researchers are testing a product commonly used to treat ticks and fleas on pets to target fly and mosquito larvae ...

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

Aerobic exercise has been linked with Parkinson's disease progression and risk. ( Washington Post) Air purifiers in residential aged-care facilities did not reduce the incidence of acute respiratory ...